|
1
|
Zibelman M and Mehra R: Overview of
current treatment options and investigational targeted therapies
for locally advanced squamous cell carcinoma of the head and neck.
Am J Clin Oncol. 39:396–406. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jayanthi P, Varun BR and Selvaraj J:
Epithelial-mesenchymal transition in oral squamous cell carcinoma:
An insight into molecular mechanisms and clinical implications. J
Oral Maxillofac Pathol. 24:1892020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Thomson PJ: Perspectives on oral squamous
cell carcinoma prevention-proliferation, position, progression and
prediction. J Oral Pathol Med. 47:803–807. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zaid KW, Nhar BM, Ghadeer Alanazi SM,
Murad R, Domani A and Alhafi AJ: Lack of effects of recombinant
human bone morphogenetic Protein2 on angiogenesis in oral squamous
cell carcinoma induced in the syrian hamster cheek pouch. Asian Pac
J Cancer Prev. 17:3527–3531. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
D'Silva NJ, Perez-Pacheco C and Schmitd
LB: The 3D's of neural phenotypes in oral cancer: Distance,
diameter, and density. Adv Biol (Weinh). 7:e22001882023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Torres-Ferrús M, Ursitti F, Alpuente A,
Brunello F, Chiappino D, de Vries T, Di Marco S, Ferlisi S,
Guerritore L, Gonzalez-Garcia N, et al: From transformation to
chronification of migraine: Pathophysiological and clinical
aspects. J Headache Pain. 21:422020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Serafini MS, Lopez-Perez L, Fico G,
Licitra L, De Cecco L and Resteghini C: Transcriptomics and
Epigenomics in head and neck cancer: Available repositories and
molecular signatures. Cancers Head Neck. 5:22020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hede K: Superhighway or blind alley? The
cancer genome atlas releases first results. J Natl Cancer Inst.
100:1566–1569. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fu X, Cheng S, Wang W, Shi O, Gao F, Li Y
and Wang Q: TCGA dataset screening for genes implicated in
endometrial cancer using RNA-seq profiling. Cancer Genet. 254–255.
40–47. 2021.
|
|
12
|
Gene Ontology Consortium: The gene
ontology resource: Enriching a GOld mine. Nucleic Acids Res.
49(D1): D325–D334. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu M, Yang F and Xu Y: Identification of
potential drug therapy for dermatofibrosarcoma protuberans with
bioinformatics and deep learning technology. Curr Comput Aided Drug
Des. 18:393–405. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Toruner GA, Ulger C, Alkan M, Galante AT,
Rinaggio J, Wilk R, Tian B, Soteropoulos P, Hameed MR, Schwalb MN
and Dermody JJ: Association between gene expression profile and
tumor invasion in oral squamous cell carcinoma. Cancer Genet
Cytogenet. 154:27–35. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheu JJ, Lee CC, Hua CH, Li CI, Lai MT,
Lee SC, Cheng J, Chen CM, Chan C, Chao SC, et al: LRIG1 modulates
aggressiveness of head and neck cancers by regulating
EGFR-MAPK-SPHK1 signaling and extracellular matrix remodeling.
Oncogene. 33:1375–1384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen Y, Dong S, Liu J, Zhang L, Zhang J,
Zhou H and Dong W: Identification of potential biomarkers for
thyroid cancer using bioinformatics strategy: A study based on GEO
datasets. Biomed Res Int. 2020:97104212020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wooller SK, Benstead-Hume G, Chen X, Ali Y
and Pearl FMG: Bioinformatics in translational drug discovery.
Biosci Rep. 37:BSR201601802017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ogoshi K, Kasamatsu A, Iyoda M, Sakuma K,
Yamatoji M, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H and Uzawa K:
Dickkopf-1 in human oral cancer. Int J Oncol. 39:329–336.
2011.PubMed/NCBI
|
|
20
|
Wang Z, Wang J, Chen Z, Wang K and Shi L:
MicroRNA-1-3p inhibits the proliferation and migration of oral
squamous cell carcinoma cells by targeting DKK1. Biochem Cell Biol.
96:355–364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huo Q, Xu C, Shao Y, Yu Q, Huang L, Liu Y
and Bao H: Free CA125 promotes ovarian cancer cell migration and
tumor metastasis by binding Mesothelin to reduce DKK1 expression
and activate the SGK3/FOXO3 pathway. Int J Biol Sci. 17:574–588.
2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chi C, Li M, Hou W, Chen Y, Zhang Y and
Chen J: Long noncoding RNA SNHG7 activates Wnt/β-catenin signaling
pathway in cervical cancer cells by epigenetically silencing DKK1.
Cancer Biother Radiopharm. 35:329–337. 2020.PubMed/NCBI
|
|
23
|
Sun YS, Zhao Z, Yang ZN, Xu F, Lu HJ, Zhu
ZY, Shi W, Jiang J, Yao PP and Zhu HP: Risk factors and preventions
of breast cancer. Int J Biol Sci. 13:1387–1397. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Niu J, Li XM, Wang X, Liang C, Zhang YD,
Li HY, Liu FY, Sun H, Xie SQ and Fang D: DKK1 inhibits breast
cancer cell migration and invasion through suppression of
β-catenin/MMP7 signaling pathway. Cancer Cell Int. 19:1682019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goetz JG, Minguet S, Navarro-Lérida I,
Lazcano JJ, Samaniego R, Calvo E, Tello M, Osteso-Ibáñez T,
Pellinen T, Echarri A, et al: Biomechanical remodeling of the
microenvironment by stromal caveolin-1 favors tumor invasion and
metastasis. Cell. 146:148–163. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xue M, Zhu Y, Jiang Y, Han L, Shi M, Su R,
Wang L, Xiong C, Wang C, Wang T, et al: Schwann cells regulate
tumor cells and cancer-associated fibroblasts in the pancreatic
ductal adenocarcinoma microenvironment. Nat Commun. 14:46002023.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Luo G, Zhang L, Wu W, Zhang L, Lin J, Shi
H, Wu X, Yu Y, Qiu W, Chen J, et al: Upregulation of ubiquitin
carboxy-terminal hydrolase 47 (USP47) in papillary thyroid
carcinoma ex vivo and reduction of tumor cell malignant behaviors
after USP47 knockdown by stabilizing SATB1 expression in vitro.
Oncol Lett. 26:3702023.PubMed/NCBI
|
|
28
|
Zheng W, Qian C, Tang Y, Yang C, Zhou Y,
Shen P, Chen W, Yu S, Wei Z, Wang A, et al: Manipulation of the
crosstalk between tumor angiogenesis and immunosuppression in the
tumor microenvironment: Insight into the combination therapy of
anti-angiogenesis and immune checkpoint blockade. Front Immunol.
13:10353232022. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Johnson A, Townsend M and O'Neill K: Tumor
microenvironment immunosuppression: A roadblock to CAR T-cell
advancement in solid tumors. Cells. 11:36262022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Suresh K, Naidoo J, Lin CT and Danoff S:
Immune checkpoint immunotherapy for non-small cell lung cancer:
Benefits and pulmonary toxicities. Chest. 154:1416–1423. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Betella I, Turbitt WJ, Szul T, Wu B,
Martinez A, Katre A, Wall JA, Norian L, Birrer MJ and Arend R: Wnt
signaling modulator DKK1 as an immunotherapeutic target in ovarian
cancer. Gynecol Oncol. 157:765–774. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang Q, Zhao M, Lin S, Han Q, Ye H, Peng
F and Li L: Prediction of prognosis and immunotherapy response in
lung adenocarcinoma based on CD79A, DKK1 and VEGFC. Heliyon.
9:e185032023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Arend R, Dholakia J, Castro C, Matulonis
U, Hamilton E, Jackson CG, LyBarger K, Goodman HM, Duska LR, Mahdi
H, et al: DKK1 is a predictive biomarker for response to DKN-01:
Results of a phase 2 basket study in women with recurrent
endometrial carcinoma. Gynecol Oncol. 172:82–91. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chu HY, Chen Z, Wang L, Zhang ZK, Tan X,
Liu S, Zhang BT, Lu A, Yu Y and Zhang G: Dickkopf-1: A promising
target for cancer immunotherapy. Front Immunol. 12:6580972021.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wall JA, Klempner SJ and Arend RC: The
anti-DKK1 antibody DKN-01 as an immunomodulatory combination
partner for the treatment of cancer. Expert Opin Investig Drugs.
29:639–644. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Phillips C, Bhamra I, Eagle C, Flanagan E,
Armer R, Jones CD, Bingham M, Calcraft P, Edmenson Cook A, Thompson
B and Woodcock SA: The Wnt pathway inhibitor RXC004 blocks tumor
growth and reverses immune evasion in Wnt ligand-dependent cancer
models. Cancer Res Commun. 2:914–928. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lyu H, Zhang J, Wei Q, Huang Y, Zhang R,
Xiao S, Guo D, Chen XZ, Zhou C and Tang J: Identification of
Wnt/β-catenin- and autophagy-related lncRNA signature for
predicting immune efficacy in pancreatic adenocarcinoma. Biology
(Basel). 12:3192023.PubMed/NCBI
|
|
38
|
Muto S, Enta A, Maruya Y, Inomata S,
Yamaguchi H, Mine H, Takagi H, Ozaki Y, Watanabe M, Inoue T, et al:
Wnt/β-catenin signaling and resistance to immune checkpoint
inhibitors: From non-small-cell lung cancer to other cancers.
Biomedicines. 11:1902023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
D'Souza LC, Shekher A, Challagundla KB,
Sharma A and Gupta SC: Reprogramming of glycolysis by chemical
carcinogens during tumor development. Semin Cancer Biol.
87:127–136. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Taieb J, Svrcek M, Cohen R, Basile D,
Tougeron D and Phelip JM: Deficient mismatch repair/microsatellite
unstable colorectal cancer: Diagnosis, prognosis and treatment. Eur
J Cancer. 175:136–157. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lamb NA, Bard JE, Loll-Krippleber R, Brown
GW and Surtees JA: Complex mutation profiles in mismatch repair and
ribonucleotide reductase mutants reveal novel repair substrate
specificity of MutS homolog (MSH) complexes. Genetics.
221:iyac0922022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kašubová I, Holubeková V, Janíková K,
Váňová B, Sňahničanová Z, Kalman M, Plank L and Lasabová Z: Next
generation sequencing in molecular diagnosis of lynch syndrome-a
pilot study using new stratification criteria. Acta Medica (Hradec
Kralove). 61:98–102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Castiglia D, Bernardini S, Alvino E,
Pagani E, De Luca N, Falcinelli S, Pacchiarotti A, Bonmassar E,
Zambruno G and D'Atri S: Concomitant activation of Wnt pathway and
loss of mismatch repair function in human melanoma. Genes
Chromosomes Cancer. 47:614–624. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Suzuki H, Hirata Y, Suzuki N, Ihara S,
Sakitani K, Kobayashi Y, Kinoshita H, Hayakawa Y, Yamada A, Watabe
H, et al: Characterization of a new small bowel adenocarcinoma cell
line and screening of anti-cancer drug against small bowel
adenocarcinoma. Am J Pathol. 185:550–562. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie X, Chen J, Wo D, Ma E, Ning Y, Peng J,
Zhu W and Ren DN: Babao Dan is a robust anti-tumor agent via
inhibiting wnt/β-catenin activation and cancer cell stemness. J
Ethnopharmacol. 280:1144492021. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hashemi M, Hasani S, Hajimazdarany S,
Ghadyani F, Olyaee Y, Khodadadi M, Ziyarani MF, Dehghanpour A,
Salehi H, Kakavand A, et al: Biological functions and molecular
interactions of Wnt/β-catenin in breast cancer: Revisiting
signaling networks. Int J Biol Macromol. 232:1233772023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Alshahrani SH, Rakhimov N, Rana A, Alsaab
HO, Hjazi A, Adile M, Abosaooda M, Abdulhussien Alazbjee AA,
Alsalamy A and Mahmoudi R: Dishevelled: An emerging therapeutic
oncogene in human cancers. Pathol Res Pract. 250:1547932023.
View Article : Google Scholar : PubMed/NCBI
|
